XOMA Royalty Corporation (XOMAP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
2200 Powell Street
Emeryville, CA 94608
United States of America (the)
Phone
510 204 7200
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
14
First IPO Date
December 16, 2020
| Name | Title | Pay | Year Born |
| Owen Hughes Jr. | Chief Executive Officer & Director | 1.14M | 1975 |
| Brad Sitko | Chief Investment Officer | 853,495 | 1981 |
| Juliane Snowden | Head of Investor Relations | 0 | N/A |
| Jeffrey Trigilio | Chief Financial Officer | 0 | 1984 |
| Maricel Perea Montano | Chief Legal Officer & Corporate Secretary | 0 | N/A |
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.